Alliance in the News RSS
The NCI Alliance for Nanotechnology in Cancer is conducting cutting-edge research using nanotechnology to transform the diagnosis, prevention, treatment, and clinical outcomes for cancer patients. Read news stories and announcements below about the Alliance's multidisciplinary work.
- Pfizer Makes Nanomedicines Deal With Bind Therapeutics
Bloomberg — April 3, 2013
- Langer startup BINDs nanomedicine and drug targeting in $180M-plus Amgen deal
FierceDrugDelivery — January 8, 2013
- Beckman Researchers Lead Nanopore Effort at Illinois
Beckman Institute News — January 8, 2013